Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 1
1979 1
2015 1
2017 2
2018 2
2019 3
2020 4
2021 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Performance of a novel Next Generation Sequencing circulating tumor DNA (ctDNA) platform for the evaluation of samples from patients with metastatic breast cancer (MBC).
Gerratana L, Zhang Q, Shah AN, Davis AA, Zhang Y, Wehbe F, Qiang W, Flaum L, Finkelman BS, Gradishar WJ, Platanias LC, Behdad A, Cristofanilli M. Gerratana L, et al. Among authors: flaum l. Crit Rev Oncol Hematol. 2020 Jan;145:102856. doi: 10.1016/j.critrevonc.2019.102856. Epub 2019 Dec 23. Crit Rev Oncol Hematol. 2020. PMID: 31884205 Review.
Reply to T. Shimoi et al and Y. Shimanuki et al.
Mayer IA, Zhao F, Arteaga CL, Symmans WF, Park BH, Burnette BL, Tevaarwerk AJ, Garcia SF, Smith KL, Makower DF, Block M, Morley KA, Jani CR, Mescher C, Dewani SJ, Tawfik B, Flaum LE, Mayer EL, Sikov WM, Rodler ET, Wagner LI, DeMichele AM, Sparano JA, Wolff AC, Miller KD. Mayer IA, et al. Among authors: flaum le. J Clin Oncol. 2021 Nov 1;39(31):3522-3524. doi: 10.1200/JCO.21.01905. Epub 2021 Sep 23. J Clin Oncol. 2021. PMID: 34554848 Free PMC article. No abstract available.
Landscape of circulating tumour DNA in metastatic breast cancer.
Davis AA, Jacob S, Gerratana L, Shah AN, Wehbe F, Katam N, Zhang Q, Flaum L, Siziopikou KP, Platanias LC, Gradishar WJ, Behdad A, Cristofanilli M. Davis AA, et al. Among authors: flaum l. EBioMedicine. 2020 Aug;58:102914. doi: 10.1016/j.ebiom.2020.102914. Epub 2020 Jul 21. EBioMedicine. 2020. PMID: 32707446 Free PMC article.
The Use of Serial Circulating Tumor DNA to Detect Resistance Alterations in Progressive Metastatic Breast Cancer.
Jacob S, Davis AA, Gerratana L, Velimirovic M, Shah AN, Wehbe F, Katam N, Zhang Q, Flaum L, Siziopikou KP, Platanias LC, Gradishar WJ, Behdad A, Bardia A, Cristofanilli M. Jacob S, et al. Among authors: flaum l. Clin Cancer Res. 2021 Mar 1;27(5):1361-1370. doi: 10.1158/1078-0432.CCR-20-1566. Epub 2020 Dec 15. Clin Cancer Res. 2021. PMID: 33323406
Randomized Phase III Postoperative Trial of Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy: ECOG-ACRIN EA1131.
Mayer IA, Zhao F, Arteaga CL, Symmans WF, Park BH, Burnette BL, Tevaarwerk AJ, Garcia SF, Smith KL, Makower DF, Block M, Morley KA, Jani CR, Mescher C, Dewani SJ, Tawfik B, Flaum LE, Mayer EL, Sikov WM, Rodler ET, Wagner LI, DeMichele AM, Sparano JA, Wolff AC, Miller KD. Mayer IA, et al. Among authors: flaum le. J Clin Oncol. 2021 Aug 10;39(23):2539-2551. doi: 10.1200/JCO.21.00976. Epub 2021 Jun 6. J Clin Oncol. 2021. PMID: 34092112 Free PMC article. Clinical Trial.
Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer.
Gerratana L, Davis AA, Zhang Q, Basile D, Rossi G, Strickland K, Franzoni A, Allegri L, Mu Z, Zhang Y, Flaum LE, Damante G, Gradishar WJ, Platanias LC, Behdad A, Yang H, Puglisi F, Cristofanilli M. Gerratana L, et al. Among authors: flaum le. JCO Precis Oncol. 2021 Jun 8;5:943-952. doi: 10.1200/PO.20.00345. eCollection 2021 Jun. JCO Precis Oncol. 2021. PMID: 34136741 Free PMC article.
A pilot study of cabergoline for the treatment of metastatic breast cancer.
Costa R, Santa-Maria CA, Scholtens DM, Jain S, Flaum L, Gradishar WJ, Clevenger CV, Kaklamani VG. Costa R, et al. Among authors: flaum l. Breast Cancer Res Treat. 2017 Oct;165(3):585-592. doi: 10.1007/s10549-017-4370-x. Epub 2017 Jul 3. Breast Cancer Res Treat. 2017. PMID: 28674764 Clinical Trial.
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Smith KL, Zhao F, Mayer IA, Tevaarwerk AJ, Garcia SF, Arteaga CL, Symmans WF, Park BH, Burnette BL, Makower DF, Block M, Morley KA, Jani CR, Mescher C, Dewani SJ, Brown-Glaberman U, Flaum LE, Mayer EL, Sikov WM, Rodler ET, DeMichele AM, Sparano JA, Wolff AC, Miller KD, Wagner LI. Smith KL, et al. Among authors: flaum le. Cancer. 2024 Jan 18. doi: 10.1002/cncr.35187. Online ahead of print. Cancer. 2024. PMID: 38236702
18 results